NuvoResearch.com NuvoResearch.com
Mailing ListMailing ListContactsContactsStock QuoteStock QuoteSite MapSite Map
Transdermal Delivery
Immune Regulation
Home
Company Company
History & Milestones
Executive Team
Subsidiaries
Distribution Partners
Pipeline Pipeline
Transdermal Drug Delivery
Immune Regulation
Technology Technology
MMPE
HTE
Investors Investors
News Releases
Financial Reports
Webcasts and Presentations
Corporate Governance
Shareholder Information
Info Request
Publications Publications
Transdermal Delivery
Immune Regulation
Technology
Careers Careers

News Releases


News releases may contain forward-looking statements, subject to risks and uncertainties beyond Nuvo's control. All news releases were accurate when issued. Actual results could differ materially from those expressed and Nuvo undertakes no obligation to revise the information in light of future events.

Year: 2010 : 2009 : 2008 : 2007


July 29,
2010
Nuvo Announces Second Quarter 2010 Financial Results
April 29, 2010 Nuvo Announces First Quarter 2010 Financial Results
April 27, 2010 Nuvo Announces U.S. Availability of Pennsaid
March 17, 2010 Nuvo Announces Completed Redemption of 5% Convertible Debentures
March 15, 2010 Nuvo Announces First Patient Enrolled in Phase 2 WF10 Allergic Rhinitis Trial
February 19, 2010 Nuvo Announces Fourth Quarter & Year-End Results
February 4, 2010 Nuvo Announces Early Redemption of 5% Convertible Debentures
     
   
   
   
   
   
   
   
   
   
   
   

All news releases are in PDF format. To view the news releases you will need Adobe Acrobat Reader installed on your computer.

Back to top